Article
Camptothecin inhibits Tat-mediated transactivation of type 1 human immunodeficiency virus.
1 Mar 1994
Abstract excerpt
Transcription of type 1 human immunodeficiency virus (HIV-1) is governed by the viral long terminal repeat (LTR). By using HIV-1 LTR-directed reporter gene systems, we found that the DNA topoisomerase I inhibitor camptothecin inhibits Tat-mediated transactivation of HIV-1 LTR. The 293.27.2 cells that carry a stably transfected HIV-1 LTR-directed lacZ gene expression vector (pNAZ) were used. Inhibitions of LTR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
